Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Metall ZugLTS:0QLX 60 Receivables Turnover is 3.38 as of Dec. 2025. GuruFocus rates LTS:0QLX with a GF Score™ of 60/100 and a GF Value™ of CHF762.37 (Fairly Valued). The stock has 3 warning signs investors should review. Among 812 Medical Devices & Instruments companies, Metall Zug ranks better than 61.58% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Metall Zug's Revenue for the
six
months ended in Dec. 2025 was CHF100.4 Mil. Metall Zug's average Accounts Receivable for the
six
months ended in Dec. 2025 was CHF29.7 Mil.
Hence, Metall Zug's Receivables Turnover for the
six
months ended in Dec. 2025 was 3.38.
Metall Zug (LTS:0QLX) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Metall Zug Receivables Turnover Related Terms
Metall Zug Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Metall Zug's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0QLX vs ABT, SYK, MDT: Receivables Turnover Comparison
For the Medical Devices subindustry, Metall Zug's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Metall Zug Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Metall Zug's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Metall Zug's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Metall Zug (LTS:0QLX) has a Receivables Turnover of 3.38 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Metall Zug and its competitors. According to the industry distribution chart, Metall Zug ranks #312 out of 812 companies in the Medical Devices & Instruments industry, placing it in the top 38.4%.
Is Metall Zug's Receivables Turnover too high?
Metall Zug's current Receivables Turnover is 3.38. The Medical Devices & Instruments industry median Receivables Turnover is 5.51. Metall Zug's value of 3.38 is 38.7% below this industry median. Based on the distribution chart, Metall Zug ranks #312 out of 812 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Metall Zug has a GF Score™ of 60/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Metall Zug's Receivables Turnover compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Metall Zug ranks #312 out of 812 companies for Receivables Turnover. This puts Metall Zug in the upper half of its industry. The industry median Receivables Turnover is 5.51. Metall Zug's value of 3.38 is 38.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.51, based on 812 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Metall Zug's current Receivables Turnover of 3.38 is 38.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Metall Zug and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Metall Zug's current Receivables Turnover is 3.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metall Zug stock overvalued right now?
Based on GuruFocus' analysis, Metall Zug (LTS:0QLX) is currently considered Fairly Valued. The stock's GF Value™ is CHF762.37, compared to a current price of CHF729.00 — trading 4.4% below its estimated fair value. The current Receivables Turnover is 3.38 and 38.7% below the Medical Devices & Instruments industry median of 5.51. Metall Zug's overall GF Score™ is 60/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Metall Zug (LTS:0QLX), the current Receivables Turnover is 3.38 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Metall Zug (LTS:0QLX) Overvalued in 2026?
Based on GuruFocus' analysis, Metall Zug stock appears to be undervalued.
The current stock price of CHF729.00 is trading 4.4% below its estimated GF Value™ of CHF762.37.
GuruFocus considers Metall Zug to be Fairly Valued.
Key valuation signals for LTS:0QLX:
Receivables Turnover: 3.38
GF Value™: CHF762.37 vs. price of CHF729.00 (4.4% below fair value)
Industry Position: 38.7% below the Medical Devices & Instruments median (#312 of 812)
No single metric tells the full story. See the LTS:0QLX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Metall Zug Ltd is engaged in the industrial sector. The company is organized, into business segments namely; Medical Devices which comprises of products and services for diagnosis and surgery, mainly in the fields of ophthalmology and microsurgery; Technologycluster & Infrastructure is engaged in Management and development of real estate; and Investments & Corporate. The majority of its revenue is generated from the Medical Devices segment. Geographically, the company operates in Switzerland, Europe (excluding Switzerland), the Americas, and Asia /Pacific/Others, and the majority of its revenue is generated from the Americas region.
60GF Score
Get the complete analysis for LTS:0QLX
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0QLX has been successfully added to your 
